Hob Biotech Group Stock Shares Owned By Insiders

688656 Stock   111.45  1.35  1.23%   
HOB Biotech Group fundamentals help investors to digest information that contributes to HOB Biotech's financial success or failures. It also enables traders to predict the movement of HOB Stock. The fundamental analysis module provides a way to measure HOB Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HOB Biotech stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

HOB Biotech Group Company Shares Owned By Insiders Analysis

HOB Biotech's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current HOB Biotech Shares Owned By Insiders

    
  77.69 %  
Most of HOB Biotech's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HOB Biotech Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 77% of HOB Biotech Group are shares owned by insiders. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The shares owned by insiders for all China stocks is notably lower than that of the firm.

HOB Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HOB Biotech's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HOB Biotech could also be used in its relative valuation, which is a method of valuing HOB Biotech by comparing valuation metrics of similar companies.
HOB Biotech is currently under evaluation in shares owned by insiders category among its peers.

HOB Fundamentals

About HOB Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze HOB Biotech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HOB Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HOB Biotech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in HOB Stock

HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.